Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1985 2
1986 1
1993 1
1994 1
1995 1
1996 2
1997 2
1998 6
1999 7
2001 2
2002 3
2003 6
2004 5
2005 5
2006 9
2007 8
2008 12
2009 19
2010 11
2011 11
2012 11
2013 11
2014 14
2015 9
2016 14
2017 8
2018 15
2019 30
2020 27
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

232 results
Results by year
Filters applied: . Clear all
Page 1
SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study.
Lecuru FR, McCormack M, Hillemanns P, Anota A, Leitao M, Mathevet P, Zweemer R, Fujiwara K, Zanagnolo V, Zahl Eriksson AG, Hudson E, Ferron G, Plante M. Lecuru FR, et al. Among authors: ferron g. Int J Gynecol Cancer. 2019 May;29(4):829-834. doi: 10.1136/ijgc-2019-000332. Epub 2019 Mar 20. Int J Gynecol Cancer. 2019. PMID: 30898938 Free PMC article. Clinical Trial.
Novel Surgical Strategies in the Treatment of Gynecological Malignancies.
Angeles MA, Martínez-Gómez C, Migliorelli F, Voglimacci M, Figurelli J, Motton S, Tanguy Le Gac Y, Ferron G, Martinez A. Angeles MA, et al. Among authors: ferron g. Curr Treat Options Oncol. 2018 Nov 9;19(12):73. doi: 10.1007/s11864-018-0582-5. Curr Treat Options Oncol. 2018. PMID: 30411170 Review.
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Classe JM, Loaec C, Gimbergues P, Alran S, de Lara CT, Dupre PF, Rouzier R, Faure C, Paillocher N, Chauvet MP, Houvenaeghel G, Gutowski M, De Blay P, Verhaeghe JL, Barranger E, Lefebvre C, Ngo C, Ferron G, Palpacuer C, Campion L. Classe JM, et al. Among authors: ferron g. Breast Cancer Res Treat. 2019 Jan;173(2):343-352. doi: 10.1007/s10549-018-5004-7. Epub 2018 Oct 20. Breast Cancer Res Treat. 2019. PMID: 30343457 Clinical Trial.
[CHIP and ovarian cancer].
Lécuru F, Bakrin N, Classe JM, Colombo PE, Ferron G, Freyer G, Glehen O, Gouy S, Huchon C, Narducci F, Pocard M, Pomel C, Rouzier R. Lécuru F, et al. Among authors: ferron g. Gynecol Obstet Fertil Senol. 2019 Sep;47(9):617-618. doi: 10.1016/j.gofs.2019.06.007. Epub 2019 Jun 26. Gynecol Obstet Fertil Senol. 2019. PMID: 31252153 French. No abstract available.
Surgery in reference centers improves survival of sarcoma patients: a nationwide study.
Blay JY, Honoré C, Stoeckle E, Meeus P, Jafari M, Gouin F, Anract P, Ferron G, Rochwerger A, Ropars M, Carrere S, Marchal F, Sirveaux F, Di Marco A, Le Nail LR, Guiramand J, Vaz G, Machiavello JC, Marco O, Causeret S, Gimbergues P, Fiorenza F, Chaigneau L, Guillemin F, Guilloit JM, Dujardin F, Spano JP, Ruzic JC, Michot A, Soibinet P, Bompas E, Chevreau C, Duffaud F, Rios M, Perrin C, Firmin N, Bertucci F, Le Pechoux C, Le Loarer F, Collard O, Karanian-Philippe M, Brahmi M, Dufresne A, Dupré A, Ducimetière F, Giraud A, Pérol D, Toulmonde M, Ray-Coquard I, Italiano A, Le Cesne A, Penel N, Bonvalot S; NETSARC/REPPS/RESOS and French Sarcoma Group–Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) Networks. Blay JY, et al. Among authors: ferron g. Ann Oncol. 2019 Jul 1;30(7):1143-1153. doi: 10.1093/annonc/mdz124. Ann Oncol. 2019. PMID: 31081028 Free PMC article.
Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies.
Balança CC, Scarlata CM, Michelas M, Devaud C, Sarradin V, Franchet C, Martinez Gomez C, Gomez-Roca C, Tosolini M, Heaugwane D, Lauzéral-Vizcaino F, Mir-Mesnier L, Féliu V, Valle C, Pont F, Ferron G, Gladieff L, Motton S, Tanguy Le Gac Y, Dupret-Bories A, Sarini J, Vairel B, Illac C, Siegfried-Vergnon A, Mery E, Fournié JJ, Vergez S, Delord JP, Rochaix P, Martinez A, Ayyoub M. Balança CC, et al. Among authors: ferron g. Cancer Immunol Res. 2020 Jul;8(7):869-882. doi: 10.1158/2326-6066.CIR-19-0855. Epub 2020 Apr 15. Cancer Immunol Res. 2020. PMID: 32295784
Urinary diversion after pelvic exenteration for gynecologic malignancies.
Martínez-Gómez C, Angeles MA, Martinez A, Malavaud B, Ferron G. Martínez-Gómez C, et al. Among authors: ferron g. Int J Gynecol Cancer. 2021 Jan;31(1):1-10. doi: 10.1136/ijgc-2020-002015. Epub 2020 Nov 23. Int J Gynecol Cancer. 2021. PMID: 33229410 Free PMC article. Review.
Traitement des rechutes tardives du cancer de l’ovaire.
Floquet A, Berton-Rigaud D, Ferron G, Freyer G, Hardy-Bessard AC, You B. Floquet A, et al. Among authors: ferron g. Bull Cancer. 2017 May;104 Suppl 1:S24-S31. doi: 10.1016/S0007-4551(17)30159-5. Bull Cancer. 2017. PMID: 28625312 French.
Bricker ileal conduit diversion in 10 steps.
Martínez-Gómez C, Angeles MA, Sanson C, Bernard M, Martinez A, Ferron G. Martínez-Gómez C, et al. Among authors: ferron g. Int J Gynecol Cancer. 2020 Feb;30(2):279. doi: 10.1136/ijgc-2019-000899. Epub 2019 Dec 1. Int J Gynecol Cancer. 2020. PMID: 31792087 No abstract available.
PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells.
Balança CC, Salvioni A, Scarlata CM, Michelas M, Martinez-Gomez C, Gomez-Roca C, Sarradin V, Tosolini M, Valle C, Pont F, Ferron G, Gladieff L, Vergez S, Dupret-Bories A, Mery E, Rochaix P, Fournié JJ, Delord JP, Devaud C, Martinez A, Ayyoub M. Balança CC, et al. Among authors: ferron g. JCI Insight. 2021 Jan 25;6(2):e142513. doi: 10.1172/jci.insight.142513. JCI Insight. 2021. PMID: 33332284 Free PMC article.
232 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page